42 related articles for article (PubMed ID: 32911926)
21. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
23. METTL3-mediated m
Zhou YF; Li JT; Zheng QL; Ren KL; Yi CC
Kaohsiung J Med Sci; 2024 Feb; 40(2):150-160. PubMed ID: 38088510
[TBL] [Abstract][Full Text] [Related]
24. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
25. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
Lei Y; Wang YH; Wang XF; Bai J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
[TBL] [Abstract][Full Text] [Related]
26. Anti-Obesity Medications in Cancer Therapy: A Comprehensive Insight.
Shekhawat R; Mandal CC
Curr Cancer Drug Targets; 2021; 21(6):476-494. PubMed ID: 34225630
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis.
Kumar N; Mandal CC
Front Genet; 2021; 12():724149. PubMed ID: 34603386
[TBL] [Abstract][Full Text] [Related]
28. Protein therapeutics as an emerging strategy to deal with skin cancer: A short review.
Kulshrestha S; Goel A
Exp Dermatol; 2024 Jan; 33(1):e14981. PubMed ID: 37983960
[TBL] [Abstract][Full Text] [Related]
29. Aloperine: A Potent Modulator of Crucial Biological Mechanisms in Multiple Diseases.
Tahir M; Ali S; Zhang W; Lv B; Qiu W; Wang J
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453655
[TBL] [Abstract][Full Text] [Related]
30. Exploring Dysregulated Signaling Pathways in Cancer.
Nisar S; Hashem S; Macha MA; Yadav SK; Muralitharan S; Therachiyil L; Sageena G; Al-Naemi H; Haris M; Bhat AA
Curr Pharm Des; 2020; 26(4):429-445. PubMed ID: 31939726
[TBL] [Abstract][Full Text] [Related]
31. TRAF5 promotes the occurrence and development of colon cancer via the activation of PI3K/AKT/NF-κB signaling pathways.
Sun G; Zheng C; Deng Z; Huang C; Huang J
J Biol Regul Homeost Agents; 2020; 34(4):1257-1268. PubMed ID: 32911926
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
[TBL] [Abstract][Full Text] [Related]
33. The role of PIP5K1A in cancer development and progression.
Yin M; Wang Y
Med Oncol; 2022 Jul; 39(10):151. PubMed ID: 35852640
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
